Vol 11: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.Report as inadecuate



 Vol 11: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.


Vol 11: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy. - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 11: Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy.
This article is from World Journal of Surgical Oncology, volume 11.AbstractBackground: Accurate predictors of survival for patients with advanced gastric cancer treated with neoadjuvant chemotherapy are currently lacking. In this study, we aimed to evaluate the prognostic significance of the neutrophil-lymphocyte ratio (NLR) in patients with stage

Author: Jin, Hailong; Zhang, Geer; Liu, Xiaosun; Liu, Xiaokun; Chen, Chao; Yu, Hang; Huang, Xiaomei; Zhang, Qing; Yu, Jiren

Source: https://archive.org/







Related documents